Infections with human cytomegalovirus (HCMV) are often asymptomatic in healthy adults but can be severe in people with a compromised immune system. While several studies have demonstrated associations between cardiovascular disease in older adults and HCMV seropositivity, the underlying mechanisms are unclear. We review evidence published within the last 5 years establishing how HCMV can contribute directly and indirectly to the development and progression of atherosclerotic plaques. We also discuss associations between HCMV infection and cardiovascular outcomes in populations with a high or very high burden of HCMV, including patients with renal or autoimmune disease, transplant recipients, and people living with HIV.
Get full access to this article
View all access options for this article.
References
1.
AffandiJS, LeeS, ChihH, et al. Cytomegalovirus burden improves a predictive model identifying measures of vascular risk in renal transplant recipients and healthy adults. J Med Virol, 2020. [Epub ahead of print]; doi: 10.1002/jmv.25697
2.
AlanioC, VermaA, MathewD, et al. Cytomegalovirus latent infection is associated with an increased risk of COVID-19-related hospitalization. J Infect Dis, 2022.226(3):463–473; doi: 10.1093/infdis/jiac020
3.
AlsulamiK, SadouniM, Tremblay-SherD, et al.High frequencies of adaptive NK cells are associated with absence of coronary plaque in cytomegalovirus infected people living with HIV. Medicine (Baltimore), 2022; 101(38):e30794; doi: 10.1097/MD.0000000000030794
4.
AriyantoIA, EstiasariR, KarimB, et al.Which NK cell populations mark the high burden of CMV present in all HIV patients beginning ART in Indonesia?. AIDS Res Ther, 2022; 19(1):16; doi: 10.1186/s12981-022-00439-2
5.
AriyantoIA, EstiasariR, WatersS, et al.Active and persistent cytomegalovirus infections affect T cells in young adult HIV patients commencing antiretroviral therapy. Viral Immunol, 2018; 31(6):472–479; doi: 10.1089/vim.2018.0014
6.
AslamY, WilliamsonJ, RomashovaV, et al.Human cytomegalovirus upregulates expression of HCLS1 resulting in increased cell motility and transendothelial migration during latency. iScience, 2019; 20:60–72; doi: 10.1016/j.isci.2019.09.016
7.
BallegaardV, PedersenKK, BraendstrupP, et al.Cytomegalovirus-specific CD8+ T-cell responses are associated with arterial blood pressure in people living with HIV. PLoS One, 2020; 15(1):e0226182; doi: 10.1371/journal.pone.0226182
8.
BarnesS, SchilizziO, AudsleyKM, et al.Deciphering the immunological phenomenon of adaptive natural killer (NK) cells and cytomegalovirus (CMV). Int J Mol Sci, 2020; 21(22):8864; doi: 10.3390/ijms21228864
9.
BartlettB, LudewickHP, MisraA, et al.Macrophages and T cells in atherosclerosis: A translational perspective. Am J Physiol Heart Circ Physiol, 2019; 317(2):H375–H386; doi: 10.1152/ajpheart.00206.2019
10.
BasatemurGL, JorgensenHF, ClarkeMCH, et al.Vascular smooth muscle cells in atherosclerosis. Nat Rev Cardiol, 2019; 16(12):727–744; doi: 10.1038/s41569-019-0227-9
11.
BeyazMO, UgurlucanM, OztasDM, et al.Evaluation of the relationship between plaque formation leading to symptomatic carotid artery stenosis and cytomegalovirus by investigating the virus DNA. Arch Med Sci Atheroscler Dis, 2019; 4:e19–e24; doi: 10.5114/amsad.2019.83304
12.
BrodinP, CasariG, TownsendL, et al.Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat Med, 2022; 28(5):879–882.
13.
CaoJ, MaoY, DongB, et al.Detection of specific Chlamydia pneumoniae and cytomegalovirus antigens in human carotid atherosclerotic plaque in a Chinese population. Oncotarget, 2017; 8(33):55435–55442; doi: 10.18632/oncotarget.19314
14.
ChanouzasD, SagmeisterM, DyallL, SharpP, PowleyL, JohalS, et al.The host cellular immune response to cytomegalovirus targets the endothelium and is associated with increased arterial stiffness in ANCA-associated vasculitis. Arthritis Res Ther, 2018; 20(1):194; doi: 10.1186/s13075-018-1695-8
15.
ChenB, MorrisSR, PanigrahiS, et al.Cytomegalovirus coinfection is associated with increased vascular-homing CD57(+) CD4 T cells in HIV infection. J Immunol, 2020; 204(10):2722–2733; doi: 10.4049/jimmunol.1900734
16.
ChenG, YangX, WangB, et al.Human cytomegalovirus promotes the activation of TGF-beta1 in human umbilical vein endothelial cells by MMP-2 after endothelial mesenchymal transition. Adv Clin Exp Med, 2019a;28(11):1441–1450; doi: 10.17219/acem/109199
17.
ChenQ, LvJ, YangW, et al.Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis. Theranostics, 2019b;9(22):6424–6442; doi: 10.7150/thno.35528
18.
ChenS, PawelecG, TrompetS, et al.Associations of cytomegalovirus infection with all-cause and cardiovascular mortality in multiple observational cohort studies of older adults. J Infect Dis, 2021; 223(2):238–246; doi: 10.1093/infdis/jiaa480
19.
ChowdhuryRR, D'AddabboJ, HuangX, et al.Human coronary plaque T cells are clonal and cross-react to virus and self. Circ Res, 2022; 130(10):1510–1530; doi: 10.1161/CIRCRESAHA.121.320090
20.
EdwarL, KarimB, WijayaIP, et al.Factors affecting the health of retinal vessels in human immunodeficiency virus patients beginning anti-retroviral therapy. AIDS Res Hum Retroviruses, 2019; 35(6):529–535; doi: 10.1089/AID.2018.0251
21.
ForteE, ZhangZ, ThorpEB, et al.Cytomegalovirus latency and reactivation: An intricate interplay with the host immune response. Front Cell Infect Microbiol, 2020; 10:130; doi: 10.3389/fcimb.2020.00130
22.
FreemanML, LedermanMM, GianellaS. Partners in crime: The role of CMV in immune dysregulation and clinical outcome during HIV infection. Curr HIV/AIDS Rep, 2016; 13(1):10–19; doi: 10.1007/s11904-016-0297-9
23.
FritzNM, StammingerT, Ramsperger-GleixnerM, et al.Cytomegalovirus chemokine receptor M33 knockout reduces chronic allograft rejection in a murine aortic transplant model. Transpl Immunol, 2021; 64:101359; doi: 10.1016/j.trim.2020.101359
24.
GaballaA, AlagrafiF, UhlinM, et al.Revisiting the role of gammadelta T cells in anti-CMV immune response after transplantation. Viruses, 2021; 13(6):1031; doi: 10.3390/v13061031
25.
GargA, GianellaS, NakazawaM, et al.Association of cytomegalovirus DNA and immunologic markers of cardiovascular disease. Open Forum Infect Dis, 2019; 6(5):ofz113; doi: 10.1093/ofid/ofz113
26.
GuizaniI, ZidiW, ZayaniY, et al.Matrix metalloproteinase-3 predicts clinical cardiovascular outcomes in patients with coronary artery disease: A 5years cohort study. Mol Biol Rep, 2019; 46(5):4699–4707; doi: 10.1007/s11033-019-04914-4
HabibiS, GhaffarpasandE, ShojaeiF, et al.Prognostic value of biomarkers in cardiac allograft vasculopathy following heart transplantation: A literature review. Cardiology, 2020; 145(11):693–702; doi: 10.1159/000509630
29.
HarmanJL, JorgensenHF. The role of smooth muscle cells in plaque stability: Therapeutic targeting potential. Br J Pharmacol, 2019; 176(19):3741–3753; doi: 10.1111/bph.14779
30.
HoehlS, BergerA, CiesekS, RabenauHF. Thirty years of CMV seroprevalence—A longitudinal analysis in a German university hospital. Eur J Clin Microbiol Infect Dis, 2020; 39(6):1095–1102; doi: 10.1007/s10096-020-03814-x
31.
JankowskiJ, FloegeJ, FliserD, et al.Cardiovascular disease in chronic kidney disease: Pathophysiological insights and therapeutic options. Circulation, 2021; 143(11):1157–1172; doi: 10.1161/circulationaha.120.050686
32.
JaworowskiA, HearpsAC, AngelovichTA, et al.How monocytes contribute to increased risk of atherosclerosis in virologically-suppressed HIV-positive individuals receiving combination antiretroviral therapy. Front Immunol, 2019; 10:1378; doi: 10.3389/fimmu.2019.01378
33.
JiaYJ, LiuJ, HanFF, et al.Cytomegalovirus infection and atherosclerosis risk: A meta-analysis. J Med Virol, 2017; 89(12):2196–2206; doi: 10.1002/jmv.24858
34.
KalayiniaS, ArjmandF, MalekiM, et al.MicroRNAs: Roles in cardiovascular development and disease. Cardiovasc Pathol, 2020; 50:107296; doi: 10.1016/j.carpath.2020.107296
35.
KaminskiH, MenardC, El HayaniB, et al.Characterization of a unique gammadelta T-cell subset as a specific marker of cytomegalovirus infection severity. J Infect Dis, 2021; 223(4):655–666; doi: 10.1093/infdis/jiaa400
36.
KarangiziAHK, ChanouzasD, FentonA, et al.Cytomegalovirus seropositivity is independently associated with cardiovascular disease in non-dialysis dependent chronic kidney disease. QJM, 2020; 113(4):253–257; doi: 10.1093/qjmed/hcz258
37.
KarimB, WijayaIP, RahmaniyahR, et al.Factors affecting affect cardiovascular health in Indonesian HIV patients beginning ART. AIDS Res Ther, 2017; 14(1):52; doi: 10.1186/s12981-017-0180-9
38.
KhairallahC, Dechanet-MervilleJ, CaponeM. gammadelta T cell-mediated immunity to cytomegalovirus infection. Front Immunol, 2017; 8:105; doi: 10.3389/fimmu.2017.00105
39.
KhoukazHB, JiY, BraetDJ, et al.Drug targeting of plasminogen activator inhibitor-1 inhibits metabolic dysfunction and atherosclerosis in a murine model of metabolic syndrome. Arterioscler Thromb Vasc Biol, 2020; 40(6):1479–1490; doi: 10.1161/ATVBAHA.119.313775
40.
KnudsenA, KristoffersenUS, PanumI, et al.Coronary artery calcium and intima-media thickness are associated with level of cytomegalovirus immunoglobulin G in HIV-infected patients. HIV Med, 2019; 20(1):60–62; doi: 10.1111/hiv.12672
41.
KnudsenA, ThorsteinssonK, ChristensenTE, et al.Cardiac microvascular dysfunction in women living with HIV is associated with cytomegalovirus immunoglobulin G. Open Forum Infect Dis, 2018; 5(9):ofy205; doi: 10.1093/ofid/ofy205
42.
KoupenovaM, MickE, CorkreyHA, et al.Micro RNAs from DNA viruses are found widely in plasma in a large observational human population. Sci Rep, 2018; 8(1):6397; doi: 10.1038/s41598-018-24765-6
43.
Le Balc'hP, PinceauxK, PronierC, et al.Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients. Crit Care, 2020; 24(1):530; doi: 10.1186/s13054-020-03252-3
44.
LebedevaA, MaryukhnichE, GrivelJC, et al.Productive cytomegalovirus infection is associated with impaired endothelial function in ST-elevation myocardial infarction. Am J Med, 2020; 133(1):133–142; doi: 10.1016/j.amjmed.2019.06.021
45.
LeeS, AffandiJS, IrishAB, et al.Cytomegalovirus infection alters phenotypes of different gammadelta T-cell subsets in renal transplant recipients with long-term stable graft function. J Med Virol, 2017a;89(8):1442–1452; doi: 10.1002/jmv.24784
46.
LeeS, BartlettB, DwivediG. Adaptive immune responses in human atherosclerosis. Int J Mol Sci, 2020; 21(23):9322; doi: 10.3390/ijms21239322
47.
LeeS, BrookE, AffandiJ, et al.A high burden of cytomegalovirus marks poor vascular health in transplant recipients more clearly than in the general population. Clin Transl Immunology, 2019a;8(2):e1043; doi: 10.1002/cti2.1043
48.
LeeS, ChungYH, LeeC. US28, a virally-encoded GPCR as an antiviral target for human cytomegalovirus infection. Biomol Ther (Seoul), 2017b;25(1):69–79.
49.
LeeS, DoualehM, AffandiJS, et al.Functional and clinical consequences of changes to natural killer cell phenotypes driven by chronic cytomegalovirus infections. J Med Virol, 2019b;91(6):1120–1127; doi: 10.1002/jmv.25401
50.
LiB, XiaY, HuB. Infection and atherosclerosis: TLR-dependent pathways. Cell Mol Life Sci, 2020a;77(14):2751–2769; doi: 10.1007/s00018-020-03453-7
51.
LiD, LiB, YangL, et al. Human cytomegalovirus infection is correlated with atherosclerotic plaque vulnerability in carotid artery. J Gene Med, 2020b:e3236; doi: 10.1002/jgm.3236
52.
LiHZ, WangQ, ZhangYY, et al.Onset of coronary heart disease is associated with HCMV infection and increased CD14 (+)CD16 (+) monocytes in a population of Weifang, China. Biomed Environ Sci, 2020c;33(8):573–582; doi: 10.3967/bes2020.076
53.
LiL, DuZ, RongB, et al.Foam cells promote atherosclerosis progression by releasing CXCL12. Biosci Rep, 2020d;40(1):BSR20193267; doi: 10.1042/BSR20193267
54.
LiL, LiY, DaiZ, et al.Lipid metabolism in vascular smooth muscle cells influenced by HCMV infection. Cell Physiol Biochem, 2016a;39(5):1804–1812; doi: 10.1159/000447880
55.
LiL, LiuM, KangL, et al.HHEX: A crosstalker between HCMV infection and proliferation of VSMCs. Front Cell Infect Microbiol, 2016b;6:169; doi: 10.3389/fcimb.2016.00169
56.
LiM, WangZW, FangLJ, et al.Programmed cell death in atherosclerosis and vascular calcification. Cell Death Dis, 2022; 13(5):467; doi: 10.1038/s41419-022-04923-5
57.
LiuY, ZhangHG. Vigilance on new-onset atherosclerosis following SARS-CoV-2 infection. Front Med (Lausanne), 2020; 7:629413; doi: 10.3389/fmed.2020.629413
58.
LiuZX, JiHH, YaoMP, et al.Serum Metrnl is associated with the presence and severity of coronary artery disease. J Cell Mol Med, 2019; 23(1):271–280; doi: 10.1111/jcmm.13915
59.
LollingaWT, de WitRH, RahbarA, et al.Human cytomegalovirus-encoded receptor US28 is expressed in renal allografts and facilitates viral spreading in vitro. Transplantation, 2017; 101(3):531–540; doi: 10.1097/TP.0000000000001289
60.
LvYL, JiaY, WanZ, et al.Curcumin inhibits the formation of atherosclerosis in ApoE(-/-) mice by suppressing cytomegalovirus activity in endothelial cells. Life Sci, 2020; 257:117658; doi: 10.1016/j.lfs.2020.117658
61.
MakwanaN, WatersS, IrishA, et al.Deciphering effects of uncontrolled cytomegalovirus replication on immune responses in cytomegalovirus DNA-positive renal transplant recipients. Viral Immunol, 2019; 32(8):355–360; doi: 10.1089/vim.2019.0014
62.
MerckelbachS, van der VorstEPC, KallmayerM, et al.Expression and cellular localization of CXCR4 and CXCL12 in human carotid atherosclerotic plaques. Thromb Haemost, 2018; 118(1):195–206; doi: 10.1160/TH17-04-0271
63.
NennaR, ZhaiJ, PackardSE, et al.High cytomegalovirus serology and subsequent COPD-related mortality: A longitudinal study. ERJ Open Res, 2020; 6(2):0062-2020; doi: 10.1183/23120541.00062-2020
64.
NguyenPM, AbdirahmanSM, PutoczkiTL. Emerging roles for Interleukin-11 in disease. Growth Factors, 2019; 37(1–2):1–11; doi: 10.1080/08977194.2019.1620227
65.
NikitskayaE, LebedevaA, IvanovaO, et al.Cytomegalovirus-productive infection is associated with acute coronary syndrome. J Am Heart Assoc, 2016; 5(8):e003759; doi: 10.1161/JAHA.116.003759
66.
OkbaAM, Abd El Raouf RaafatM, Nazmy FarresM, et al.Expanded peripheral CD4(+)CD28(null) T cells and its association with atherosclerotic changes in patients with end stage renal disease on hemodialysis. Hum Immunol, 2019; 80(9):748–754; doi: 10.1016/j.humimm.2019.03.008
67.
OlejarzW, LachetaD, Kubiak-TomaszewskaG. Matrix metalloproteinases as biomarkers of atherosclerotic plaque instability. Int J Mol Sci, 2020; 21(11):3946; doi: 10.3390/ijms21113946
68.
PatroARK. Subversion of immune response by human cytomegalovirus. Front Immunol, 2019; 10:1155; doi: 10.3389/fimmu.2019.01155
69.
PeraA, CasertaS, AlbaneseF, et al.CD28(null) pro-atherogenic CD4 T-cells explain the link between CMV infection and an increased risk of cardiovascular death. Theranostics, 2018; 8(16):4509–4519; doi: 10.7150/thno.27428
70.
Rodriguez-GoncerI, Fernandez-RuizM, AguadoJM. A critical review of the relationship between post-transplant atherosclerotic events and cytomegalovirus exposure in kidney transplant recipients. Expert Rev Anti Infect Ther, 2020; 18(2):113–125; doi: 10.1080/14787210.2020.1707079
71.
SamsonLD, van den BergSP, EngelfrietP, et al.Limited effect of duration of CMV infection on adaptive immunity and frailty: Insights from a 27-year-long longitudinal study. Clin Transl Immunology, 2020; 9(10):e1193; doi: 10.1002/cti2.1193
72.
SchaferS, ZerneckeA. CD8(+) T cells in atherosclerosis. Cells, 2020; 10(1):37; doi: 10.3390/cells10010037
73.
ShahASV, StelzleD, LeeKK, et al.Global burden of atherosclerotic cardiovascular disease in people living with HIV: Systematic review and meta-analysis. Circulation, 2018; 138(11):1100–1112; doi: 10.1161/circulationaha.117.033369
74.
ShenK, XuL, ChenD, et al.Human cytomegalovirus-encoded miR-UL112 contributes to HCMV-mediated vascular diseases by inducing vascular endothelial cell dysfunction. Virus Genes, 2018; 54(2):172–181; doi: 10.1007/s11262-018-1532-9
75.
SillenM, DeclerckPJ. Targeting PAI-1 in cardiovascular disease: Structural insights into PAI-1 functionality and inhibition. Front Cardiovasc Med, 2020; 7:622473; doi: 10.3389/fcvm.2020.622473
76.
SkodaM, StangretA, SzukiewiczD. Fractalkine and placental growth factor: A duet of inflammation and angiogenesis in cardiovascular disorders. Cytokine Growth Factor Rev, 2018; 39:116–123; doi: 10.1016/j.cytogfr.2017.12.001
77.
SlotMC, KroonAA, DamoiseauxJ, et al.CD4(+)CD28(null) T cells are related to previous cytomegalovirus infection but not to accelerated atherosclerosis in ANCA-associated vasculitis. Rheumatol Int, 2017; 37(5):791–798; doi: 10.1007/s00296-016-3643-8
78.
SouilholC, HarmsenMC, EvansPC, et al.Endothelial-mesenchymal transition in atherosclerosis. Cardiovasc Res, 2018; 114(4):565–577; doi: 10.1093/cvr/cvx253
79.
SoumyaRS, UnniTG, RaghuKG. Impact of COVID-19 on the cardiovascular system: A review of available reports. Cardiovasc Drugs Ther, 2021; 35(3):411–425; doi: 10.1007/s10557-020-07073-y
80.
StylesJN, ConverseRR, GriffinSM, et al.Human cytomegalovirus infections are associated with elevated biomarkers of vascular injury. Front Cell Infect Microbiol, 2020; 10:334; doi: 10.3389/fcimb.2020.00334
81.
Suarez-PierreA, GiulianoK, LuiC, et al.Impact of cytomegalovirus serologic status on heart transplantation. J Card Surg, 2020; 35(7):1431–1438; doi: 10.1111/jocs.14588
82.
TheodorouK, BoonRA. Endothelial cell metabolism in atherosclerosis. Front Cell Dev Biol, 2018; 6:82; doi: 10.3389/fcell.2018.00082
83.
TianY, HeY, ZhangL, et al.Role of vasodilator-stimulated phosphoprotein in human cytomegalovirus-induced hyperpermeability of human endothelial cells. Exp Ther Med, 2018; 16(2):1295–1303; doi: 10.3892/etm.2018.6332
84.
TuCC, ArnoldsKL, O'ConnorCM, et al.Human cytomegalovirus UL111A and US27 gene products enhance the CXCL12/CXCR4 signaling axis via distinct mechanisms. J Virol, 2018; 92(5):e01981-17; doi: 10.1128/JVI.01981-17
85.
UdeIN, YehS, ShanthaJG. Cytomegalovirus retinitis in the highly active anti-retroviral therapy era. Ann Eye Sci, 2022; 7:5; doi: 10.21037/aes-21-18
86.
Valle OsegueraCA, SpencerJV. Human cytomegalovirus interleukin-10 enhances matrigel invasion of MDA-MB-231 breast cancer cells. Cancer Cell Int, 2017; 17:24; doi: 10.1186/s12935-017-0399-5
87.
van den BergSPH, PardieckIN, LanfermeijerJ, et al.The hallmarks of CMV-specific CD8 T-cell differentiation. Med Microbiol Immunol, 2019; 208(3–4):365–373; doi: 10.1007/s00430-019-00608-7
88.
van den BergSPH, WongA, HendriksM, et al.Negative effect of age, but not of latent cytomegalovirus infection on the antibody response to a novel influenza vaccine strain in healthy adults. Front Immunol, 2018; 9:82; doi: 10.3389/fimmu.2018.00082
89.
WahlinB, FasthAER, KarpK, et al.Atherosclerosis in rheumatoid arthritis: Associations between anti-cytomegalovirus IgG antibodies, CD4+CD28null T-cells, CD8+CD28null T-cells and intima-media thickness. Clin Exp Rheumatol, 2021; 39(3):578–586; doi: 10.55563/clinexprheumatol/gs3o43
90.
WangF, ChenHZ. Histone deacetylase SIRT1, smooth muscle cell function, and vascular diseases. Front Pharmacol, 2020; 11:537519; doi: 10.3389/fphar.2020.537519
91.
WangH, PengG, BaiJ, et al.Cytomegalovirus infection and relative risk of cardiovascular disease (ischemic heart disease, stroke, and cardiovascular death): A meta-analysis of prospective studies up to 2016. J Am Heart Assoc, 2017; 6(7):e005025; doi: 10.1161/JAHA.116.005025
92.
WangZ, CaiJ, ZhangM, et al.Positive expression of human cytomegalovirus phosphoprotein 65 in atherosclerosis. Biomed Res Int, 2016; 2016:4067685; doi: 10.1155/2016/4067685
93.
WanjallaCN, MashayekhiM, BailinS, et al.Anticytomegalovirus CD4(+) T cells are associated with subclinical atherosclerosis in persons with HIV. Arterioscler Thromb Vasc Biol, 2021; 41(4):1459–1473; doi: 10.1161/ATVBAHA.120.315786
94.
WatersS, AgostinoM, LeeS, et al.Sequencing directly from clinical specimens reveals genetic variations in HCMV-encoded chemokine receptor US28 that may influence antibody levels and interactions with human chemokines. Microbiol Spectr, 2021; 9(2):e0002021; doi: 10.1128/Spectrum.00020-21
95.
WatersS, BrookE, LeeS, et al.HIV patients, healthy aging and transplant recipients can reveal the hidden footprints of CMV. Clin Immunol, 2018; 187:107–112; doi: 10.1016/j.clim.2017.11.001
96.
WatersS, LeeS, AffandiJS, et al.The effect of genetic variants affecting NK cell function on cardiovascular health and the burden of CMV. Hum Immunol, 2017; 78(11–12):747–751; doi: 10.1016/j.humimm.2017.10.003
97.
WatersS, LeeS, AriyantoI, et al.Sequencing of the viral UL111a gene directly from clinical specimens reveals variants of HCMV-encoded IL-10 that are associated with altered immune responses to HCMV. Int J Mol Sci, 2022; 23(9):4644; doi: 10.3390/ijms23094644
98.
WatersS, LeeS, LloydM, et al.The detection of CMV in saliva can mark a systemic infection with CMV in renal transplant recipients. Int J Mol Sci, 2019; 20(20):5230; doi: 10.3390/ijms20205230
99.
WatersS, LeeS, MunyardK, et al.Human cytomegalovirus-encoded microRNAs Can be found in saliva samples from renal transplant recipients. Noncoding RNA, 2020; 6(4):50; doi: 10.3390/ncrna6040050
100.
WeberS, KehlV, ErberJ, et al.CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients. PLoS One, 2022; 17(5):e0268530; doi: 10.1371/journal.pone.0268530
101.
WulandariEAT, WijayaIP, KarimB, et al.Periodontitis and cytomegalovirus associate with atherosclerosis among HIV patients after 5years on ART. J Acquir Immune Defic Syndr, 2020; 85(2):195–200; doi: 10.1097/QAI.0000000000002417
102.
XuH, JiangJ, ChenW, et al.Vascular macrophages in atherosclerosis. J Immunol Res, 2019; 2019:4354786; doi: 10.1155/2019/4354786
103.
YangFJ, ShuKH, ChenHY, et al.Anti-cytomegalovirus IgG antibody titer is positively associated with advanced T cell differentiation and coronary artery disease in end-stage renal disease. Immun Ageing, 2018; 15:15; doi: 10.1186/s12979-018-0120-0
104.
YeJ, WangZ, YeD, et al.Increased interleukin-11 levels are correlated with cardiac events in patients with chronic heart failure. Mediators Inflamm, 2019; 2019:1575410; doi: 10.1155/2019/1575410
105.
YounJC, KimJY, JungMK, et al.Analysis of cytomegalovirus-specific T-cell responses in patients with hypertension: Comparison of assay methods and antigens. Clin Hypertens, 2018; 24:5; doi: 10.1186/s40885-018-0090-8
106.
YuHT, YounJC, KimJH, et al.Arterial stiffness is associated with cytomegalovirus-specific senescent CD8(+) T cells. J Am Heart Assoc, 2017; 6(9):e006535; doi: 10.1161/JAHA.117.006535
107.
ZhangK, QinX, ZhouX, et al.Analysis of genes and underlying mechanisms involved in foam cells formation and atherosclerosis development. PeerJ, 2020a;8:e10336; doi: 10.7717/peerj.10336
108.
ZhangL, YuJ, LiuZ. MicroRNAs expressed by human cytomegalovirus. Virol J, 2020b;17(1):34; doi: 10.1186/s12985-020-1296-4
109.
ZhangS, LiuL, WangR, et al.miR-138 promotes migration and tube formation of human cytomegalovirus-infected endothelial cells through the SIRT1/p-STAT3 pathway. Arch Virol, 2017; 162(9):2695–2704; doi: 10.1007/s00705-017-3423-0
110.
ZhangX, TangN, XiD, et al.Human cytomegalovirus promoting endothelial cell proliferation by targeting regulator of G-protein signaling 5 hypermethylation and downregulation. Sci Rep, 2020c;10(1):2252; doi: 10.1038/s41598-020-58680-6
111.
ZhenJ, ZengM, ZhengX, et al.Human cytomegalovirus infection is associated with stroke in women: The US National Health and Nutrition Examination Survey 1999–2004. Postgrad Med J, 2022; 98(1157):172–176; doi: 10.1136/postgradmedj-2020-139201
112.
ZhouW, XiD, ShiY, et al.MicroRNA19293p participates in murine cytomegalovirusinduced hypertensive vascular remodeling through Ednra/NLRP3 inflammasome activation. Int J Mol Med, 2021; 47(2):719–731; doi: 10.3892/ijmm.2020.4829
113.
ZhuW, ZhangH, WangS. Vitamin D3 suppresses human cytomegalovirus-induced vascular endothelial apoptosis via rectification of paradoxical m6a modification of mitochondrial calcium Uniporter mRNA, which is regulated by METTL3 and YTHDF3. Front Microbiol, 2022; 13:861734; doi: 10.3389/fmicb.2022.861734
114.
ZuhairM, SmitGSA, WallisG, et al.Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis. Rev Med Virol, 2019; 29(3):e2034; doi: 10.1002/rmv.2034
